Article citationsMore>>

Broderick, J.M. (2018) FDA Approves Iobenguane I-131 for Rare Neuroendocrine Tumors.
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-iobenguane-i-131-rare-adrenal-gland-tumors

has been cited by the following article: